Temat: "Antigens, CD34" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Stem Cells mobilization and collection in allogeneic related and unrelated donors: a single center experience with focus on plerixafor.
Autorzy:: Marcon C; Departement of Blood Transfusion Medicine, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; Department of Medicine (DAME), University of Udine, Udine, Italy.
Bertone A; Departement of Blood Transfusion Medicine, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Mauro S; Departement of Blood Transfusion Medicine, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Mestroni R; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Battaglia G; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; Department of Medicine (DAME), University of Udine, Udine, Italy.
Pizzano U; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; Department of Medicine (DAME), University of Udine, Udine, Italy.
Facchin G; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
De Martino M; Department of Medicine (DAME), University of Udine, Udine, Italy.
Isola M; Department of Medicine (DAME), University of Udine, Udine, Italy.
Patriarca F; Division of Hematology, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Barillari G; Departement of Blood Transfusion Medicine, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Savignano C; Departement of Blood Transfusion Medicine, S. Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy. Electronic address: .; Pokaż więcej
Źródło:: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2023 Dec; Vol. 62 (6), pp. 103845. Date of Electronic Publication: 2023 Nov 03.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Heterocyclic Compounds*/pharmacology
Heterocyclic Compounds*/therapeutic use
Hematopoietic Stem Cell Transplantation*
Humans ; Hematopoietic Stem Cell Mobilization ; Cohort Studies ; Retrospective Studies ; Unrelated Donors ; Prospective Studies ; Granulocyte Colony-Stimulating Factor/pharmacology ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Body Weight ; Antigens, CD34/metabolism

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: The impact of diabetes mellitus on hematopoietic stem cell mobilization, a-single center cohort study.
Autorzy:: Çelik S; Department of Hematology, Yenimahalle Training and Research Hospital, Yıldırım Beyazıt University, Ankara, Turkiye. Electronic address: .
Kaynar L; Department of Hematology, Faculty of Medicine, Medipol Mega University, İstanbul, Turkiye.
Güven ZT; Department of Hematology, Adana City Hospital, Adana, Turkiye.
Begendi NK; Department of Hematology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkiye.
Demir F; Department of Medical Genetics, Ankara Bilkent City Hospital, Ankara, Turkiye.
Keklik M; Department of Hematology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye.
Ünal A; Department of Hematology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye.; Pokaż więcej
Źródło:: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2023 Dec; Vol. 62 (6), pp. 103838. Date of Electronic Publication: 2023 Oct 22.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus*
Hematopoietic Stem Cell Transplantation*
Humans ; Hematopoietic Stem Cell Mobilization/methods ; Cohort Studies ; Retrospective Studies ; Granulocyte Colony-Stimulating Factor/pharmacology ; Antigens, CD34/metabolism

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection.
Autorzy:: Lanza F; Hematology Unit and Romagna Metropolitan Transplant Network, University Hospital, Ravenna & Universty of Bologna, Italy.
Marchetti M; Hematology Unit, Ospedale di Asti, Italy.
Zannetti BA; Hematology Unit and Romagna Metropolitan Transplant Network, University Hospital, Ravenna, Italy.; Pokaż więcej
Źródło:: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2023 Dec; Vol. 62 (6), pp. 103830. Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:: Editorial
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/methods
Heterocyclic Compounds*/pharmacology
Multiple Myeloma*/therapy
Humans ; Hematopoietic Stem Cell Mobilization/methods ; Artificial Intelligence ; Antigens, CD34/metabolism ; Transplantation, Autologous ; Hematopoietic Stem Cells/metabolism ; Granulocyte Colony-Stimulating Factor/pharmacology

Opinia redakcyjna

na półce

Szczegóły

Skocz do pozycji: 4.

Tytuł:: Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors.
Autorzy:: Cao J; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China. .; Institute of Hematology, Ningbo University, Ningbo, China. .
Li A; Department of Gastrointestinal Surgery, Ningbo University, Ningbo, China.
Pei R; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.; Institute of Hematology, Ningbo University, Ningbo, China.
Lu Y; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China. .; Institute of Hematology, Ningbo University, Ningbo, China. .
Chen D; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.; Institute of Hematology, Ningbo University, Ningbo, China.
Du X; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.; Institute of Hematology, Ningbo University, Ningbo, China.
Liu X; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.; Institute of Hematology, Ningbo University, Ningbo, China.
Li S; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.; Institute of Hematology, Ningbo University, Ningbo, China.
Ye P; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.; Institute of Hematology, Ningbo University, Ningbo, China.; Pokaż więcej
Źródło:: Annals of hematology [Ann Hematol] 2023 Dec; Vol. 102 (12), pp. 3567-3573. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:: Journal Article
MeSH Terms:: Peripheral Blood Stem Cells*
Hematopoietic Stem Cell Transplantation*
Peripheral Blood Stem Cell Transplantation*
Humans ; Retrospective Studies ; Hematopoietic Stem Cell Mobilization/methods ; Granulocyte Colony-Stimulating Factor ; Antigens, CD34 ; Blood Donors

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 5.

Tytuł:: Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?
Autorzy:: Serin I; University of Health Sciences, Istanbul Training and Research Hospital, Department of Hematology, Istanbul, Turkey. Electronic address: .
Sevindik OG; Istanbul Medipol University, Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
Balik Aydin B; Istanbul Medipol University, Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
Melek E; Istanbul Medipol University, Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
Mutlu YG; Istanbul Medipol University, Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
Bilgen H; Istanbul Medipol University, Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
Bekoz H; Istanbul Medipol University, Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
Kaynar L; Istanbul Medipol University, Faculty of Medicine, Department of Hematology, Istanbul, Turkey.; Pokaż więcej
Źródło:: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2023 Dec; Vol. 62 (6), pp. 103809. Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/methods
Heterocyclic Compounds*/pharmacology
Heterocyclic Compounds*/therapeutic use
Febrile Neutropenia*
Multiple Myeloma*/therapy
Adult ; Humans ; Hematopoietic Stem Cell Mobilization/methods ; Transplantation, Autologous ; Granulocyte Colony-Stimulating Factor/pharmacology ; Antigens, CD34/metabolism

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 6.

Tytuł:: Efficacy of ex vivo purging with CD34+ selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients.
Autorzy:: Jeon Y; Lymphoma and Cell Therapy-Research Center, Yeouido St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea; Catholic University Lymphoma Group, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Kim TY; Lymphoma and Cell Therapy-Research Center, Yeouido St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea; Catholic University Lymphoma Group, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Min GJ; Catholic University Lymphoma Group, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Park SS; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Park S; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Yoon JH; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Lee SE; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Cho BS; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Eom KS; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Kim YJ; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Kim HJ; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Lee S; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Min CK; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Lee JW; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Cho SG; Lymphoma and Cell Therapy-Research Center, Yeouido St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea; Catholic University Lymphoma Group, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea; Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea. Electronic address: .; Pokaż więcej
Źródło:: Cytotherapy [Cytotherapy] 2023 Dec; Vol. 25 (12), pp. 1307-1316. Date of Electronic Publication: 2023 Aug 04.
Typ publikacji:: Journal Article
MeSH Terms:: Lymphoma, T-Cell, Peripheral*/therapy
Hematopoietic Stem Cell Transplantation*
Humans ; Transplantation, Autologous ; Retrospective Studies ; Neoplasm Recurrence, Local ; Antigens, CD34 ; Cell Adhesion Molecules ; Recurrence

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 7.

Tytuł:: The effect of mobilizing large numbers of CD34 + cells (super-mobilizers) on the engraftment and survival in patients undergoing autologous stem cell transplantation.
Autorzy:: Moreb JS; Hematology, Transplantation and Cellular Therapy, Novant Health Cancer Institute, Winston-Salem, NC, USA. Electronic address: .
Lantos L; Transplantation and Cellular Therapy Program, Novant Health Cancer Institute, Charlotte, NC, USA.
Chen F; Hematology, Transplantation and Cellular Therapy, Novant Health Cancer Institute, Winston-Salem, NC, USA.
Elliott K; Hematology, Transplantation and Cellular Therapy, Novant Health Cancer Institute, Winston-Salem, NC, USA.
Dugan J; Hematology, Transplantation and Cellular Therapy, Novant Health Cancer Institute, Winston-Salem, NC, USA.
Skarbnik AP; Transplantation and Cellular Therapy Program, Novant Health Cancer Institute, Charlotte, NC, USA.
Kropf PL; Transplantation and Cellular Therapy Program, Novant Health Cancer Institute, Charlotte, NC, USA.
Ward K; Transplantation and Cellular Therapy Program, Novant Health Cancer Institute, Charlotte, NC, USA.; Pokaż więcej
Źródło:: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2023 Dec; Vol. 62 (6), pp. 103787. Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Heterocyclic Compounds*/pharmacology
Lymphoma*/therapy
Multiple Myeloma*/therapy
Multiple Myeloma*/pathology
Humans ; Hematopoietic Stem Cell Mobilization/methods ; Retrospective Studies ; Transplantation, Autologous ; Granulocyte Colony-Stimulating Factor/pharmacology ; Antigens, CD34/metabolism

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 8.

Tytuł:: Manufacturing of CD34 + HPC-enriched, high-purity mononuclear cell products from umbilical cord blood.
Autorzy:: Wynn L; Anthony Nolan Cell Therapy Centre, Nottingham, UK. .
Wilson MG; Anthony Nolan Cell Therapy Centre, Nottingham, UK.
Leonforte C; Anthony Nolan Cell Therapy Centre, Nottingham, UK.; Pokaż więcej
Źródło:: Cell and tissue banking [Cell Tissue Bank] 2023 Dec; Vol. 24 (4), pp. 685-691. Date of Electronic Publication: 2023 Feb 03.
Typ publikacji:: Journal Article
MeSH Terms:: Fetal Blood*
Hematopoietic Stem Cells*
Ficoll ; Antigens, CD34/analysis ; Cryopreservation/methods ; Cell Survival

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 9.

Tytuł:: Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings.
Autorzy:: Gokarn A; Department of Medical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India.
Tembhare PR; Homi Bhabha National Institute, Mumbai, India; Hematopathology Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Syed H; Homi Bhabha National Institute, Mumbai, India; Hasan Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Sanyal I; Hematopathology Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Kumar R; Hasan Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Parab S; Department of Transfusion Medicine, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Khanka T; Hematopathology Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Punatar S; Department of Medical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India.
Kedia S; Hematopathology Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Ghogale SG; Hematopathology Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Deshpande N; Hematopathology Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Nikam Y; Hasan Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Girase K; Hematopathology Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Mirgh S; Department of Medical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India.
Jindal N; Department of Medical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India.
Bagal B; Department of Medical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India.
Chichra A; Department of Medical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India.
Nayak L; Department of Medical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India.
Bonda A; Department of Medical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India.
Rath S; Department of Medical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India.
Hiregoudar S; Homi Bhabha National Institute, Mumbai, India; Department of Transfusion Medicine, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Poojary M; Homi Bhabha National Institute, Mumbai, India; Department of Transfusion Medicine, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Saha S; Homi Bhabha National Institute, Mumbai, India; Department of Transfusion Medicine, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Ojha S; Homi Bhabha National Institute, Mumbai, India; Department of Transfusion Medicine, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Subramanian PG; Homi Bhabha National Institute, Mumbai, India; Hematopathology Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Khattry N; Department of Medical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Center, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India.; Pokaż więcej
Źródło:: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Dec; Vol. 29 (12), pp. 777.e1-777.e8. Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:: Journal Article
MeSH Terms:: Dimethyl Sulfoxide*/pharmacology
Peripheral Blood Stem Cells*
Humans ; Freezing ; Hematopoietic Stem Cells ; Methylcellulose/pharmacology ; Resource-Limited Settings ; Trypan Blue/pharmacology ; Cryopreservation/methods ; Antigens, CD34/pharmacology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 10.

Tytuł:: TNFα induces Caspase-3 activity in hematopoietic progenitor cells CD34+, CD33+, and CD41 + of myelodysplastic syndromes.
Autorzy:: Iriani A; Department of Clinical Pathology, Faculty of Medicine, Yarsi University - Yarsi Hospital, Jl. Letjen Suprapto Kav 13, Cempaka Putih, Jakarta, 10510, Indonesia. .
Rachman A; Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Setiabudy RD; Department of Clinical Pathology, University of Indonesia, Jakarta, Indonesia.
Kresno SB; Department of Clinical Pathology, University of Indonesia, Jakarta, Indonesia.
Sudoyo AW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Arief M; Department of Clinical Pathology, Hasanuddin University, Makasar, Indonesia.
Harahap AR; Department of Clinical Pathology, University of Indonesia, Jakarta, Indonesia.
Fatina MK; Faculty of Medicine, Andalas University, Padang, Indonesia.; Pokaż więcej
Źródło:: BMC molecular and cell biology [BMC Mol Cell Biol] 2023 Nov 21; Vol. 24 (1), pp. 33. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:: Journal Article
MeSH Terms:: Tumor Necrosis Factor-alpha*
Myelodysplastic Syndromes*
Humans ; Caspase 3 ; Hematopoietic Stem Cells ; Antigens, CD34 ; Cell Adhesion Molecules ; Sialic Acid Binding Ig-like Lectin 3

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Development of a potency assay for CD34 cell-based therapy.
Autorzy:: Aries A; Institut de Recherche en Hématologie et Transplantation, Hôpital du Hasenrain, 87 Avenue d'Altkirch, Mulhouse, France.
Vignon C; CellProthera SAS, 12 Rue du Parc, Mulhouse, France.
Zanetti C; Institut de Recherche en Hématologie et Transplantation, Hôpital du Hasenrain, 87 Avenue d'Altkirch, Mulhouse, France.
Goubaud A; CellProthera SAS, 12 Rue du Parc, Mulhouse, France.
Cormier A; CellProthera SAS, 12 Rue du Parc, Mulhouse, France.
Diederichs A; CellProthera SAS, 12 Rue du Parc, Mulhouse, France.
Lahlil R; Institut de Recherche en Hématologie et Transplantation, Hôpital du Hasenrain, 87 Avenue d'Altkirch, Mulhouse, France.
Hénon P; Institut de Recherche en Hématologie et Transplantation, Hôpital du Hasenrain, 87 Avenue d'Altkirch, Mulhouse, France.; CellProthera SAS, 12 Rue du Parc, Mulhouse, France.
Garitaonandia I; CellProthera SAS, 12 Rue du Parc, Mulhouse, France. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 11; Vol. 13 (1), pp. 19665. Date of Electronic Publication: 2023 Nov 11.
Typ publikacji:: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:: Endothelial Progenitor Cells*/metabolism
MicroRNAs*/metabolism
Myocardial Infarction*/metabolism
Humans ; Antigens, CD34/metabolism ; Neovascularization, Physiologic ; Vascular Endothelial Growth Factor A/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Steady-state versus chemotherapy-based hematopoietic cell mobilization after anti-CD38-based induction therapy in newly diagnosed multiple myeloma.
Autorzy:: Teipel R; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
Rieprecht S; Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.; Pharmacy, University Leipzig Medical Center, Leipzig, Germany.
Trautmann-Grill K; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
Röllig C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
Klötzer C; Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.
Zimmer K; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
Rathaj G; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
Bach E; Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.
Brückner M; Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.
Heyn S; Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.
Wang SY; Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.
Jentzsch M; Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.
Schwind S
Kretschmann T; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
Egger-Heidrich K; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
Remane Y; Pharmacy, University Leipzig Medical Center, Leipzig, Germany.
Franke GN; Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.
von Bonin M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
Bornhäuser M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.; National Center for Tumor Disease (NCT), Dresden, Germany.
Platzbecker U; Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.
Hölig K; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
Merz M; Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.
Vučinić V; Department of Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany.; Pokaż więcej
Źródło:: Transfusion [Transfusion] 2023 Nov; Vol. 63 (11), pp. 2131-2139. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Myeloma*/drug therapy
Heterocyclic Compounds*/therapeutic use
Hematopoietic Stem Cell Transplantation*
Antineoplastic Agents*/therapeutic use
Humans ; Middle Aged ; Hematopoietic Stem Cell Mobilization/methods ; Induction Chemotherapy ; Retrospective Studies ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Granulocyte Colony-Stimulating Factor/pharmacology ; Antigens, CD34/metabolism ; Transplantation, Autologous ; Body Weight

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 13.

Tytuł:: A case of complex hemangioendothelioma of the liver in an infant.
Autorzy:: Huang W; Nuclear Medicine, Peking University First Hospital.
Li L; Radiology, The First Affiliated Hospital of Zhengzhou University.
Gao J; Radiology, The First Affiliated Hospital of Zhengzhou University.
Kang L; Nuclear Medicine, Peking University First Hospital, China.; Pokaż więcej
Źródło:: Revista espanola de enfermedades digestivas [Rev Esp Enferm Dig] 2023 Nov; Vol. 115 (11), pp. 668-670.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Hemangioendothelioma*/diagnostic imaging
Hemangioendothelioma*/surgery
Hemangioendothelioma, Epithelioid*/diagnostic imaging
Hemangioendothelioma, Epithelioid*/surgery
Female ; Infant ; Humans ; Abdomen ; Liver ; Antigens, CD34 ; Muscle Hypertonia

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 14.

Tytuł:: Engineered human Diamond-Blackfan anemia disease model confirms therapeutic effects of clinically applicable lentiviral vector at single-cell resolution.
Autorzy:: Liu Y; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund 22184, Sweden; Department of Medicine, Huddinge, Karolinska Institutet, 14157 Stockholm. .
Schmiderer L; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund 22184.
Hjort M; Chemical Biology and Therapeutics, Department of Experimental Medical Science, Lund University, 22100 Lund, Sweden; Navan Technologies, MBC Biolabs, San Carlos, CA 94070; NanoLund, Lund University, Box 118, 22100 Lund.
Lang S; Division of Molecular Hematology and Stem Cell Center, Lund University, Lund.
Bremborg T; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund 22184.
Rydström A; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund 22184.
Schambach A; Institute of Experimental Hematology, Hannover Medical School, Hannover 30625, Germany; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School.
Larsson J; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund 22184.
Karlsson S; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund 22184. .; Pokaż więcej
Źródło:: Haematologica [Haematologica] 2023 Nov 01; Vol. 108 (11), pp. 3095-3109. Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anemia, Diamond-Blackfan*/genetics
Anemia, Diamond-Blackfan*/therapy
Anemia, Diamond-Blackfan*/metabolism
Humans ; Ribosomal Proteins/genetics ; Cell Differentiation ; Erythropoiesis ; Stem Cells/metabolism ; Antigens, CD34

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 15.

Tytuł:: Guidelines for mouse and human DC generation.
Autorzy:: Lutz MB; Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
Ali S; Institute of Medical Microbiology and Hospital Hygiene, University of Düsseldorf, Düsseldorf, Germany.
Audiger C; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, 3052, Australia.
Autenrieth SE; Dendritic Cells in Infection and Cancer (F171), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine II, University of Tübingen, Tübingen, Germany.
Berod L; Institute of Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, 55131, Germany.
Bigley V; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom.
Cyran L; Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
Dalod M; CNRS, INSERM, Aix Marseille Univ, Centre d'Immunologie de Marseille-Luminy, Turing Center for Living Systems, Marseille, France.
Dörrie J; RNA-based Immunotherapy, Hautklinik, Universitätsklinikum Erlangen (UKER), Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.; Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg (CCC ER-EMN), Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Ulmenweg 18, 91054, Erlangen, Germany.
Dudziak D; Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg (CCC ER-EMN), Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany.; Deutsches Zentrum Immuntherapie (DZI), Ulmenweg 18, 91054, Erlangen, Germany.; Laboratory of Dendritic Cell Biology, Department of Dermatology, University Hospital Erlangen, Hartmannstraße 14, D-91052, Erlangen, Germany.; Medical Immunology Campus Erlangen (MICE), D-91054, Erlangen, Germany.
Flórez-Grau G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.
Giusiano L; Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, 55131, Germany.
Godoy GJ; Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, 55131, Germany.
Heuer M; Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
Krug AB; Institute for Immunology, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians-University Munich, Planegg-Martinsried, Germany.
Lehmann CHK; Laboratory of Dendritic Cell Biology, Department of Dermatology, University Hospital Erlangen, Hartmannstraße 14, D-91052, Erlangen, Germany.; Medical Immunology Campus Erlangen (MICE), D-91054, Erlangen, Germany.
Mayer CT; Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Naik SH; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, 3052, Australia.
Scheu S; Institute of Medical Microbiology and Hospital Hygiene, University of Düsseldorf, Düsseldorf, Germany.
Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.
Segura E; Institut Curie, PSL Research University, INSERM, U932, 26 rue d'Ulm, Paris, 75005, France.
Seré K; Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University Medical School, Aachen, Germany.; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
Sparwasser T; Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, 55131, Germany.
Tel J; Laboratory of Immunoengineering, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.; Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, The Netherlands.
Xu H; Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University Medical School, Aachen, Germany.; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
Zenke M; Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University Medical School, Aachen, Germany.; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.; Pokaż więcej
Źródło:: European journal of immunology [Eur J Immunol] 2023 Nov; Vol. 53 (11), pp. e2249816. Date of Electronic Publication: 2022 Oct 27.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Dendritic Cells*
Monocytes*
Animals ; Mice ; Humans ; Antigens, CD34 ; Phenotype ; Cell Differentiation

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 16.

Tytuł:: Loss of CD34 Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation.
Autorzy:: Partanen A; Department of Medicine, Kuopio University Hospital, Kuopio, Finland. Electronic address: .
Turunen A; Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
Valtola J; Department of Medicine, Central Hospital of Savonlinna, Savonlinna, Finland.
Pyörälä M; Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
Kuittinen O; Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland; Department of Oncology, Kuopio University Hospital, Kuopio, Finland; Cancer Center, Oulu University Hospital, Oulu, Finland.
Kuitunen H; Cancer Center, Oulu University Hospital, Oulu, Finland.
Vasala K; Department of Oncology, Hospital Nova of Central Finland, Jyväskylä, Finland.
Penttilä K; Department of Medicine, Central Hospital of Savonlinna, Savonlinna, Finland; Finnish Medicines Agency, Kuopio, Finland.
Kuittinen T; Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
Mäntymaa P; ISLAB Welfare Association, Kuopio Finland.
Pelkonen J; ISLAB Welfare Association, Kuopio Finland; Department of Clinical Microbiology, University of Eastern Finland, Kuopio, Finland.
Jantunen E; Department of Medicine, Kuopio University Hospital, Kuopio, Finland; Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Varmavuo V; Department of Medicine, Kymenlaakso Central Hospital, Kotka, Finland.; Pokaż więcej
Źródło:: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Nov; Vol. 23 (11), pp. e428-e435. Date of Electronic Publication: 2023 Aug 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Lymphoma, Non-Hodgkin*/therapy
Humans ; Progression-Free Survival ; Transplantation, Autologous ; Cryopreservation ; Antigens, CD34 ; Hematopoietic Stem Cell Mobilization

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 17.

Tytuł:: Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma.
Autorzy:: Okada Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Kimura F; Division of Hematology, National Defense Medical College, Tokorozawa, Japan.
Kurita N; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Takahashi H; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Shimazu Y; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.
Kataoka K; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Tsukada N; Division of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Hematology, Jichi Medical University, Tochigi, Japan.
Kurahashi S; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Nishikawa A; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Kim SW; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Hangaishi A; Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan.
Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Tokyo, Japan.
Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Aichi, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Kondo E; Department of Hematology, Kawasaki Medical School, Kurashiki, Japan.
Kawamura K; Department of Hematology, Tottori University Hospital, Yonago, Japan.
Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. Electronic address: .; Pokaż więcej
Źródło:: Cytotherapy [Cytotherapy] 2023 Nov; Vol. 25 (11), pp. 1212-1219. Date of Electronic Publication: 2023 Jun 24.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Multiple Myeloma*/therapy
Lymphoma, Non-Hodgkin*/therapy
Lymphoma, Non-Hodgkin*/etiology
Humans ; Retrospective Studies ; Blood Platelets ; Antigens, CD34 ; Transplantation, Autologous

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 18.

Tytuł:: Mesenchymal Stromal Cells from Perinatal Tissues as an Alternative for Ex Vivo Expansion of Hematopoietic Progenitor and Stem Cells from Umbilical Cord Blood.
Autorzy:: Bonilla X; Pharmaceutical Biotechnology Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
Lara AM; Pharmaceutical Biotechnology Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
Llano-León M; Advanced Therapies Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
López-González DA; Pharmaceutical Biotechnology Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
Hernández-Mejía DG; Advanced Therapies Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
Bustos RH; Therapeutic Evidence Group, Clinical Pharmacology, Universidad de La Sabana and Clínica Universidad de La Sabana, Chía 140013, Colombia.
Camacho-Rodríguez B; Pharmaceutical Biotechnology Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
Perdomo-Arciniegas AM; Cord Blood Bank, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 24; Vol. 24 (21). Date of Electronic Publication: 2023 Oct 24.
Typ publikacji:: Journal Article
MeSH Terms:: Mesenchymal Stem Cells*
Hematopoietic Stem Cell Transplantation*/methods
Hematologic Diseases*
Pregnancy ; Female ; Adult ; Humans ; Antigens, CD34 ; Fetal Blood ; Hematopoietic Stem Cells ; Coculture Techniques ; Cell Proliferation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Smoking and Diabetes Attenuate Number of CD34 Haematopoietic Stem Cells in Peripheral Blood of Patients with Advanced Peripheral Artery Disease.
Autorzy:: Sernek B; Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Kamnikar R; Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Sebestjen M; Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.; Department of Vascular Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.; Department of Cardiology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Boc A; Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.; Department of Vascular Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Boc V; Department of Vascular Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 19; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*
Peripheral Arterial Disease*
Humans ; Smoking/adverse effects ; Hematopoietic Stem Cells ; Antigens, CD34

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: CD90-targeted lentiviral vectors for HSC gene therapy.
Autorzy:: Berckmueller K; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Thomas J; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Taha EA; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Biochemistry, Ain Shams University Faculty of Science, Cairo 11566, Egypt.
Choo S; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Madhu R; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Kanestrom G; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Rupert PB; Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Strong R; Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Kiem HP; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA; Department of Pathology, University of Washington School of Medicine, Seattle, WA 98195, USA. Electronic address: .
Radtke S; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. Electronic address: .; Pokaż więcej
Źródło:: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 Oct 04; Vol. 31 (10), pp. 2901-2913. Date of Electronic Publication: 2023 Aug 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Humans ; Antigens, CD34/genetics ; Genetic Therapy/methods ; Genetic Vectors/genetics ; Hematopoietic Stem Cells

Czasopismo naukowe

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""Antigens, CD34"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język